Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel pyrazoloquinoline and pyrazolonaphthyridine derivatives claimed by Novartis

March 26, 2009

Novel GABA(A) modulator shows antinociceptive activity in vivo

March 26, 2009

Lilly presents novel gamma-secretase inhibitors

March 25, 2009

Epiphany Biosciences to file IND to study valomaciclovir adjunctive therapy in MS

March 25, 2009

Novel histamine H3 receptor antagonists claimed in AstraZeneca patent

March 25, 2009

Oxcarbazepine reduces pain in Parkinson's disease patients

March 25, 2009

Roche presents novel pyrrolodine aryl-ether compounds

March 24, 2009

Exalgo extended-release meets primary efficacy endpoint in phase III trial

March 24, 2009

FDA approves Symbyax for treatment-resistant depression

March 24, 2009

Novel histamine H3 receptor antagonist presented by Pfizer

March 24, 2009

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...